Real-time emotion sensing and interaction analysis revolutionize digital mental healthcare
LAS VEGAS, NV, September 30, 2025 /24-7PressRelease/ — Doctorpresso, a leading AI mental health technology company, will unveil Therapods at CES 2026 in Las Vegas. Billed as the world’s first AI-powered earbuds for virtual group therapy, the device delivers real-time emotion sensing and group interaction analysis at a fraction of traditional therapy costs.
Therapods integrate advanced AI and multimodal biosensing to track voice patterns, brainwaves, and heart rate variability, delivering real-time emotional insights with more than 90% accuracy. By restoring critical nonverbal cues often lost in remote therapy, the device addresses one of the biggest challenges in virtual mental healthcare.
The global mental health system continues to face significant challenges, with traditional barriers including cost, stigma, and limited access leaving wide gaps in care. Therapods aim to bridge those gaps by offering a scalable solution that delivers personalized emotional insights while maintaining clinical-grade security and privacy standards.
The technology has received notable industry validation, earning a finalist position for the 2025 GLOMO Awards at Mobile World Congress. At CES 2026, attendees will experience firsthand demonstrations of Therapods’ emotion-sensing and virtual group therapy applications, highlighting its potential to reshape digital mental healthcare.
Founded with a mission to make healthcare more accessible, Doctorpresso develops AI wearables supported by multiple patents and clinical validations. The company has emerged as a leader in digital mental health by combining rigorous scientific validation with intuitive design, ensuring both therapeutic impact and user trust.
Doctorpresso’s work has been recognized across the industry, with achievements ranging from peer-reviewed studies to global award nominations. Its solutions aim not only to support individual users but also to create a framework for scalable, preventive mental healthcare.
“Therapods represent a major leap in accessible mental health technology,” said Hwanbo Jung, CEO of Doctorpresso. “By merging advanced AI with human-centered design, we are breaking down traditional barriers and bringing proactive emotional support to people everywhere.”
Doctorpresso is exploring partnerships with corporations, telemedicine providers, and educational institutions to broaden Therapods’ reach. Its long-term vision is to establish a preventive mental health ecosystem where emotional wellbeing becomes a seamless part of everyday life.
At CES 2026, Doctorpresso will announce new collaborations and showcase how Therapods technology can be adopted across industries, reinforcing its position as a global leader in AI-powered healthcare innovation.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer:
The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at retract@kyrionmedia.com with the specific URL of the content in question. We will review and address valid requests promptly.
